EORTC’s Participation at the ESTRO Congress 2024
29 Apr 2024
We are delighted to announce EORTC’s participation at the ESTRO Congress 2024 taking place from 3 to 7 May 2024 in Glasgow, UK. This year’s theme is Radiation Oncology: Bridging the Care Gap.
Save the date for the ESTRO-EORTC joint session on innovations in re-irradiation clinical trial design on Saturday 4 May 2024, from 08:45 to 10:00 AM.
In addition to the joint session, we are proud to showcase five abstracts on the topic of radiation oncology: three oral presentations and two digital posters. For a detailed overview, please consult the table below.
ESTRO-EORTC Joint Session
| Session | Scheduled on |
|---|---|
| ESTRO-EORTC – Innovations in re-irradiation clinical trial design Session Type: Interdisciplinary Session code: 1080 |
Saturday 04 May 08:45 – 10:00 GMT+1 Hall 2 |
EORTC Abstracts
| Abstract | Scheduled on |
|---|---|
| Pattern-of-Care Analysis for Radiotherapy of Cutaneous Lymphomas among the European Organisation for Research and Treatment of Cancer (EORTC) Khaled Elsayad, Germany Session Type: Proffered Papers |
Saturday 04 May 10:30 – 11:30 GMT+1 Clyde |
| Interim results of the prospective RTQA procedures for HALT (CRUK/16/020, EORTC 1702-LCG-ROG) Daniel Portik, EORTC HQ Session Type: Proffered Papers |
Saturday 04 May 17:00 – 18:00 GMT+1 Hall 3 |
| Early Quality-of-Life after metastases-directed SBRT – results of the ESTRO & EORTC OligoCare cohort* Daniela Greto, Italy Session Type: Proffered paper |
Saturday 04 May 17:00 – 18:00 GMT+1 Hall 2 |
| Head-to-head comparison for breast RT planning: knowledge-based planning vs. deep learning solution Daniel Portik, EORTC HQ |
Digital Poster |
| A Trials within Cohorts comparing 1 fraction vs multiple-fraction SBRT in oligometastatic cancer* Piet Ost, Belgium |
Digital Poster |
*The Oligocare project is part of the E²-RADIatE platform. The E²-RADIatE platform and Oligocare project are supported by Walgreens Boots Alliance. OligoCare is also supported by Stiftung Bruckner.
Related News
CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer
24 Jun 2026
EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials
24 Jun 2026
New study confirms a key quality of life tool can be used with adolescents with cancer
9 Jun 2026
“Changing practice, improving lives”: EORTC publishes its Annual Report 2025
8 Jun 2026
This Clinical Trials Day, EORTC announces the upcoming Summit for Clinical Cancer Research
20 May 2026
Long-term EORTC trial challenges assumptions about lymph node radiation therapy in breast cancer
17 May 2026
Multinational study provides new evidence for the value of response-adapted, personalised treatment in Hodgkin lymphoma
1 May 2026
EORTC’s presence at ESTRO 2026
30 Apr 2026
Independent, academic cancer trials are vital to improve patient outcomes worldwide
28 Apr 2026
EORTC Imaging Group Becomes the Diagnostic and Therapeutic Imaging Group
24 Apr 2026
